Bradley E. Chipps, MD
93. Luskin, AT, Chipps BE, Rasouliyan, L, Miller, DP, Haselkorn, T, and Dorenbaum, A. Impact of asthma exacerbations and asthma triggers on asthma-related quality-of-life in patients with severe or difficult-to-treat asthma. The Journal of Allergy and Clinical Immunology: In Practice 2014 (In Press).
92. Chipps, BE, Anderson, CT, and Harder, J. Fractional exhaled nitric oxide of at least 100 and implications for future asthma research. Ann Allergy Asthma Immunol 2014;113:118-19.
91. Tashkin DO, Chipps BE, Trudo F, Zangrilli JG: Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect. J Asthma 2014 Feb 14. doi:10.3109/02770903.2014.895012 (Epub ahead of print)
90. Cleveland, C., Stewart, L., Chipps, B.E., and Spahn J.D. Diagnosis of Asthma in Preschool-Age Children. Clinical Asthma: Theory and Practice 2014. Chapter 6;57-64.
89. Schatz, M., Zeiger, R., Chipps, B., Dorenbaum, A., Chen, W., Hsu, J. Miller, D. and Mink, D. Phenotypes Determined by Cluster Analysis in Severe or Difficult-to-treat Asthma. J Allergy Clin Immunol 2013;133(6):1549-1556.
88. Kharrazi, M., Prach, L., Chipps, B., et al. Novel CFTR Variants Identified During the First Three Years of Cystic Fibrosis Newborn Screening in California. The Journal of Molecular Diagnostics 2013.
87. Chipps, B., and Mellon, M. Asthma. Encyclopedia of Inflammatory Diseases 2013 .
86. Chipps, B. Update in Pediatric Anaphylaxis: A Systemic Review. Clinical Pediatrics 2013;52(5):447-57.
85. Chipps, B., Zeiger, R., Dorenbaum, A., Borish, L., Wenzel, S., Miller, D., Hayden, M., Bleecker, E., Simons, E., Szefler, S., Weiss, S., Haselkorn, T., and TENOR Study Group. Assessment of asthma control and asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) observational cohort. Current Respiratory Care Reports 2012;1:259–269.
84. Chipps, B., Figliomeni, M., and Spector, S. Omalizumab: An Update on Efficacy and Safety in Moderate-to-Severe Allergic Asthma. Allergy and Asthma Proceedings 2012;33:377-85.
83. Chipps, B., Zeiger, R., Borish, L., Wenzel, S., Yegin, A., Hayden, M., Miller, D., Bleecker, E., Simons, E., Szefler, S., Weiss, S., and Haselkorn, T. Key Findings and Clinical Implications from the Epidemiology and Natural History of Asthma: Outcomes and T reatment Regiments (TENOR) Study. J Allergy Clin Immunol. 2012;130:332-42.
82. Zeiger, R., Yegin, A., Simons, E.R., Haselkorn, T., Rasouliyan, L., Szefler, S., Chipps, B.E., and the TENOR study group. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. Ann Allergy Asthma Immunol. 2012;108:81-87.
81. Dhand, R., Dolovich, M., Chipps, B., Myers, T., Restrepo, R., and Farrar.,
J. The role of nebulized therapy in the management of COPD: Evidence
and recommendations. COPD: Journal of Chronic Obstructive Pulmonary
Disease. 2011 (In Press).
80. Zeiger, R., Yegin, F., Simons, T., Haselkorn, T., Rasouliyan, S., Szefler,
S., and Chipps, B. Evaluation of the NHLBI guidelines impairment domain
for the classifying asthma control and predicting asthma exacerbations.
Ann Allergy Asthma Immunol. 2011;108(2):81-87.e3.
82. Chipps, B., Yegin, A., Borish, L., Wenzel, S., Weiss, S., Hayden, M.,
Miller, D., Bleecker, E., Simons, F., Szefler, S., Haselkorn, T. Lessons
learned from the epidemiology and natural history of asthma: Outcomes
and treatment regimens (TENOR) study. J Allergy Clin Immunol. 2011 (In
Press).
86. Sicherer, S., Wood, R., and the SECTION ON ALLERGY AND
IMMUNOLOGY. Allergy Testing in Childhood: Using Allergen-Specific IgE
Tests. Pediatrics. 2012;129(1):193-197.
85. Dhand, R., Dolovich, M., Chipps, B., Myers, T.R., Restrepo, R., Ferrar,
J.R. The role of nebulized therapy in the management of COPD: Evidence
and recommendations. Journal of Chronic Obstructive Pulmonary
Disease. 2012;9:58-72.
84. Zeiger, R., Yegin, A., Simons, E.R., Haselkorn, T., Rasouliyan, L.,
Szefler, S., Chipps, B.E., and the TENOR study group. Evaluation of the
National Heart, Lung, and Blood Institute guidelines impairment domain
for classifying asthma control and predicting asthma exacerbations. Ann
Allergy Asthma Immunol. 2012;108:81-87.
83. Zeiger, R.S., Mellon, M., Chipps, B.E., Murphy, K.R. Schatz, M., Kosinski,
M., Lampl, K., and Ramachandran, S. Test for Respiratory and Asthma
Control in Kids (TRACK™): Clinically Meaningful Changes in Score. J
Allergy Clin Immunol 2011 ( In Press).
82. Chipps, B.E. Letter to the Editor Spirometry Versus Flow Volume
Inspiratory and Expiratory Loop. Annals of Allergy, Asthma, &
Immunology 2011; 107(2): 183. View
81. Chipps, B.E. Letter to the Editor Treatment of Acute Asthma. Journal of Asthma 2011 View
80. Chipps, B.E. Letter to the Editor Novel Epinephrine Auto-Injector ( NEA):
Sharps Injury Prevention Validation and Comparable Analysis with
Epipen and Twinject. Annals of Allergy, Asthma, & Immunology 2011;
107(3): 286 View
79. Haselkorn, T., Szefler, S.J., Zeiger, R.S., Chipps, B.E., Fish, J., Kamath, T., Mink, D., and Yegin, A. Economic Burden of Impairment in Children with Severe or Difficult-to-Treat Asthma. Annals of Allergy, Asthma & Immunology 2011 View
78. Arellano, F.M., Arana, A., Wentwort, C.E., Vidaurre, C.F., and Chipps,B.E.
Prescription Patterns for Asthma Medications in Children and Adolescents in the United States. Pediatric Allergy & Immunology 2011 View
77. Chipps, B.E., Spector, S., Farrar, J., Carr, W., Meltzer, E., Storms, W., Kaliner, M., Luskin, A., Bukstein, D., Oppenheimer, J., Smart, B., Derebery, J., Harder, J., Dykewicz, M., and Benniger, M. Letter to the Editor Differences in Recommendations Between the Allergic Rhinitis and Its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters. J Allergy Clin Immunol (127)6, 1640-1641.e1. View
76. Chipps, B.E., Bacharier, L., and Harder, J. Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy. Journal of Pediatrics 2011; (158)6: 878-884. View
75. Chipps, B.E., Zeiger, R., Murphy, K., Mellon, M., Schatz, M., Kosinski, M., Lampl, K., and Ramachandran, S. Longitudinal Validation of Test for Respiratory and Asthma Control in Kids (TRACK™) in Pediatric Practices. Pediatrics 2011; 127: e737-e747. View
74. Sicherer, S.H., Mahr, T.A, and The Section on Allergy and Immunology. Clinical Report- Management of Food Allergy in the School Setting. Pediatrics 2010; 1232-39. View
73. Haselkorn, T., Szefler, S.J., Simons, F.E., Mink, D.R., Chipps, B.E., Borish, L., and Wong, D.A. Allergy, Serum immunoglobulin E, and Airflow in Children and Adolescents in Pediatric Allergy Immunol 2010;21: 1157– 1165. View
72. Andrew H. Liu, Robert S. Zeiger, PhD, Christine A. Sorkness, Nancy K. Ostrom, Bradley E. Chipps, Kathleen Rosa, Maria E. Watson, Michael S. Kaplan, John R. Meurer, Todd A. Mahr, Michael S. Blaiss, Elisabeth Piault- Louis, Jeffrey McDonald. The Childhood Asthma Control Test©1: Retrospective determination and clinical validation of a cut-point to identify children with very poorly controlled asthma. J Allergy Clin Immunol 2010;126:267-273. View
71. Nemr S. Eid, MD, Michael J. Noonan, MD, Bradley Chipps, MD, Bhash Parasuraman, PhD, Christopher J. Miller, Christopher D. O’Brien, MD, PhD. Once vs Twice-Daily Budesonide/Formoterol in 6-15 Year Olds With Stable Asthma: A Randomized Controlled Trial. Pediatrics 2010; 126(3): e565-e575. View
70. Chipps B.E. Evaluation of Infants and Children with Refractory Lower Respiratory Symptoms. An Allergy Asthma Immunol. 2010; 104: 279-283. View
69. LaForce, C.F., Carr, W., Tilles, S.A., Chipps, B.E., Storms, W., Meltzer, E.O., and Edwards, M. Evaluation of Olopatatadine Hydrochloride Nasal Spray, 0.6%, used in Combination with an Intranasal Corticosteroid in Seasonal Allergic Rhinitis. Allergy Asthma Proc. 2010; 31:132-140. View
68. Goldsobel, A., Chipps, B.E. Cough in Pediatric Population. Journal of Pediatrics 2010; 156 (3): 352-358. View
67. Benninger, M., Farrar J.R., Blaiss, M., Chipps, B.E., Ferguson, B., Krouse, J.,
Marple, B., Storms, W., and Kaliner, M. Evaluating Approved Medications to Treat Allergic Rhinitis in the United States: An Evidenced-Based Review of Efficacy for Nasal Symptoms by Class. Ann Allergy Asthma Immunol 2010; 104: 13-29. View
66. Zeiger, R.S., Chipps, B.E., Haselkorn, T., Rasouliyan, L., Simons, F.E.R.,
and Fish, J.E. Comparison of Asthma Exacerbations in Pediatric and Adult Patients with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol 2009; 24:1106-1108. View
65. Haselkorn, T., Fish, J.E., Zeiger, R.S., Szefler, S.J., Miller, D.P., Chipps, B.E., Simons, E.R., Weiss, S.T., Wenzel, S.E., Borish, L., and Bleecker, E.R. Consistently Very Poorly Controlled Asthma by the Impairment Domain of the EPR-3 Guidelines Increases Risk for Future Severe Asthma Exacerbations in the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens Study. J Allergy Clin Immunol 2009; 124: 895-902 e.4. View
64. Zeiger, R.S., Chipps, B.E., Haselkorn, T., Rasouliyan, L., Simons, E.R., and Fish, J.E. Recent Asthma Exacerbations Predict Future Exacerbations in Children with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol 2009; 124: 921-927. View
63. Chipps B.E. and Harder J. Antihistamine treatment for allergic rhinitis: Different routes, different outcomes. Allergy Asthma Proc. 2009 November-December;30(6): 589-594. View
62. Kalner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, Lanier BQ, Chipps B. Comparison of olopatadine 0.6% nasal spray versus fluticasone proprionate 50ug in the treatment of seasonal allergic rhinitis patients. Allergy Asthma Proc. 2009 May-June;30(3):255-262. View
61. Chipps B.E. Inhaled corticosteroid therapy for patients with persistent
Asthma: Learnings from studies inhaled budesonide. Allergy Athma Proc. 2009; May-June(3): 217-228. View
60. Murphy, K.R., Zeiger, R.S., Kosinski, M., Chipps, B.E., Mellon, M., Schatz,
M., Lampl, K., Hanlon, J.T., and Ramachandran, S. Test for Respiratory
and Asthma Control in Kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol 2009; 123:833-39. View
59. Miller, DP., Tom, Gladys, Rasouliyan, Lawrence and Chipps, B. Patient-Reported Outcomes among Omalizumab and Salmeterol/Fluticasone Combination Therapy Patients. Journal of Asthma, 46:2,179 — 185 View
58. Haselkorn, T., Fish, J.E., Chipps, B.E., Miller, D.P., Chen, H., and Weiss, S.T. Effect of Weight Change on Asthma-Related Health Outcomes in Patients with Severe or Difficult to Treat Asthma. Respiratory Medicine 2009;103: 274-283. View
57. Chipps, B.E. Zileuton for the Prophylaxis and Chronic Treatment of Asthma. US Respiratory Disease. 2008:15-18. View
56. Spahn, J.D., Stewart, L., Chipps, B.E. How Do You Diagnose Asthma in the Child? Clinical Asthma. 2008;6:57-74. View
55. Chipps, B.E. Asthma in Infants, Children, and Adolescents. Clinical Cornerstone. The Current and Future State of Asthma Treatment. 2008;8:4: 44-58. View
54. Chipps, B.E. Update on the 2007 National Asthma Education and Prevention Program: Guidelines for the Treatment of Asthma in Children. Supplement to Consultant for Pediatricians. 2008;7:1. View
53. Chipps, B.E. How Pediatric and Adult Asthma Differ, with Implications for Treatment. Respiratory Digest. 2008;9: 3-13. View
52. Lee, J., Haselkorn, T., Borish, L., Rasouliyan, L.H., Chipps, B.E., Wenzel, S. Risk Factors Associated with Persistent Airflow Limitation in Severe to Difficult-to-Treat Asthma. CHEST. 2007;132:1882-1889. View
51. Chipps, B.E., Sezefler, S.J., Simons, E.R., Haselkorn, T., Mink, D.R., Deniz, Y., Lee, J.H., TENOR Study Group. Demographic and Clinical Characteristics of Children and Adolescents with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol. 2007;119:1156-63. View
50. Sullivan, S.D., Rasouiyan, L., Russo, P.A., Kamath, T., Chipps, B.E., for the Tenor Study Group. Extent, Patterns, and Burden of Uncontrolled Disease in Severe or Difficult-to-Treat Asthma. Allergy. 2007;62:126-133. View
49. Chipps, B.E., Harder J. Targeted Interventions for Difficult-to-Treat Asthma. Expert Opinion. 2007;11:11-20. View
48. Chipps, B.E., Spahn, J.D. What Are the Determinates of Asthma Control? J Asthma. 2006;43:567-572. View
47. Chipps, B.E., Buhl, R., Beeh, K.M., Fox, H., Thomas, K., Reisner, C. Improvement in Quality of Life with Omalizumab in Patients with Sever Allergic Asthma. Current Medical Research and Opinion. 2006;22:2201-2208. View
46. Chipps, B.E. Letter to the Editor, Systemic Reaction to Omalizumab. Ann Allergy Asthma Immunol. 2006;97:267. View
45. Chipps, B.E., Spahn, J.D., Sorkness, C.A., Baitnger, L., Sutton, L.B., Emmett, A.H., Dorinsky, P.M. Variability in Asthma Severity in Pediatric Subjects with Asthma Previously Receiving Short-Acting B2-Agonists. J Pediatr. 2006;148:517-21. View
44. Sander, N., Fusco-Walker, S.J., McElvain, J., Chipps, B.E. Running on Empty: The Need for Dose counters on Pressurized Metered-Dose Inhalers. Ann Allergy Asthma Immunol. 2006;97:34-38. View
43. Spahn, J.D., Chipps, B.E., Office-based objective measures of lung function in childhood asthma. J Pediatr, 2006; 148: 11-15. View
42. Chipps, B.E., Haselkorn, T., Lee, J.H., Miller,
D.P., Wenzel, S.E., Gender Differences in IgE-Mediated Allergic
Asthma in the Epidemiology and Natural History of Asthma: Outcomes
and Treatment Regimens (TENOR) Study. Journal of Asthma, 2006; 43:179-184. View
41. Borish, L. Chipps, B.E., Deniz, Y., Zheng, B., Dolan, C., Total Serum IgE levels in a large cohort of subjects with severe or difficult to treat asthma. Ann Allergy Asthma Immunol.
2005;95:247-253 View
40. Chipps, B.E., Murphy, K.M., Assessment and Treatment of Acute Asthma in Children. J Pediatr 2005; 147:288-94. View
39. Chipps, B.E., Determinants of asthma and its clinical course. Ann Allergy Asthma Immunol. 2004;93:309-316 View
38. Chipps, B.E., Marshik, P.L., Targeted IgE Therapy for Patients With Moderate to Severe Asthma. Biotechnology Healthcare -July/August 2004;56-61. View
37. Ververeli, K., Chipps, B.E. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent acute asthma. Ann Allergy Asthma Immunol. 2004;92:512-522. View
36. Dolan, C.M., Fraher, K.E., Bleeker, E.R., Borish, L., Chipps, B.E., Hayden, M.L., et al. Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with
severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92:32-39. View
35. Chipps, B.E., Schnepp, C.M., Briscoe M. Budesonide Inhalation Suspension Reduces the Need for Emergency Intervention in Pediatric Asthma: A Named-Patient Case Series. J Asthma. 2003; 40:895-900. View
34. Oppenheimer, J.J., Chipps, B.E., Corbridge T.C., Fanta, C.H. Acute asthma: The basics of assessment and treatment. J Respir Dis. 2001; 23:126-141.
33. Abrahams, N.A., Colby, T.V., Chipps, B.E., Juris, A.L., Leslie, K.O. Pulmonary hemangiomas of infancy and childhood: report of two cases and review of the literature. Pediatr Dev Pathol. 2002 May-June; 5 (3): 283-292.
32. Chipps, B.E., Chipps, D.R.: A Review of the Role of Inhaled Corticosteroids in the Treatment of Acute Asthma. Clin Pediatrics. 2001; 40:185-189. View
31. Aquino, S.L., Schechter, M.S., Chiles C., Ablin, D.S., Chipps, B.E., Webb, W.R. High-Resolution Inspiratory and Expiratory CT in Older Children and Adults with Bronchopulmonary Dysplasia. Amer J Radiol:173:963-967, 1999.
30. Chipps, B.E., Moynihan, R., Schieble, T., Stene, R., Feaster, W., et al. Infants Undergoing Pyloromyotomy Are Not at Risk for Postoperative Apnea. Pediatr Pulmonol. 27:278-281, 1999.
29. Chipps, B.E., Chipps, D.R. Approach to Difficult Pediatric Asthmatic. Opin Pulm Med. 5:52-57, 1999.
28. The IMpact Study Group. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. Pediatrics 102:531-537, 1998. View
27. Loughlin, G.M., Brouillette R.T., Brooke L.J., Carroll J.L., Chipps, B.E., et al. Standards and Indications for Cardiopulmonary Sleep Studies In Children. American Journal of Respiratory and Critical Care Medicine. Vol 153, No. 2:866-878, 1996.
26. Smith, D.W., Frankel, L.R., Derish, M.T., Moody, R.R., Black, L.E., Chipps, B.E., Mathers, L.H.: High frequency jet ventilation in children with the adult respiratory distress syndrome complicated by pulmonary barotrauma. Pediatr Pulmonol. 15:279-286, 1993.
25. Chipps, B.E., Sullivan, W.F., Portnoy, J.M.,: Alpha 2A interferon for treatment of bronchiolitis caused by RSV. Pediatr Infect Dis J. 12:653-658, 1993.
24. Chipps, B.E., Naumann, P.F., Wong, G.A., Raabe, O.G.: Clinical Comparison of Gentle-Haler Actuator and Aerochamber Spacer for Metered Dose Inhaler (MDI) Use by Asthmatics. Respir Care 37:1414-1422, 1992.
23. Chipps, B.E., Blackney, D.A., Moody, R.R., Marino, J.T., Black, L.E., Ridell, R.C., Wong, G.A.: Vortan high output extended aerosol respiratory therapy for delivery on continuously nebulized terbutaline for the treatment of acute bronchospasm. Pediatric
Asthma, Allergy and Immunology 4:271-277, 1990.
22. Chipps, B.E., McClurg, D., Freidman, E.M., Adams, G.L.: Respiratory papillomas: Presentation before six months. Pediatric Pulmonology 9:125-130, 1990.
21. Davidson Ward, S.L., Keens, T.G., Chan, L.S., Ph.D., Chipps, B.E., et al: Sudden Infant Death Syndrome in infants evaluated by apnea programs in California. Pediatrics 77:451-458, 1986.
20. MacAdams, M.R., White, R.H., Chipps, B.E., et al: Reduction of serum testosterone during chronic glucocorticoid therapy. Annals of internal medicine 104:648-651, 1986.
19. Chipps, B.E., Mak, H., Menkes, H.A., Mellits, E., Schuberth, K., Talamo, R., Talamo, J., Dermutt, S., Scherr, M.M.: Do weather conditions change pulmonary function in asthmatics
at summer camp. Journal of Asthma 21:15-20, 1984.
18. Chipps, B.E., Shinnar, S., Pickard, L., Garfinkel, D.J., Haller, J.A.: Spontaneous resolution of multilobar atelectasis secondary to fibrinous mediastinitis. Journal of Pediatrics, 100:935-937, 1982.
17. Mak, H., Chipps, B.E., Menkes, H.A., Schuberth, H.C., Talamo, R.C., Permutt, S.: Diurnal variation of air and helium - oxygen flow - volume curves in asthmatic children. British J. Disease of Chest 76:51-56, 1982.
16. Hyatt, A.C., Chipps, B.E., Kumor, K.M., Mellits, E.D., Lietman, P.S., Rosentein, B.J.: A double blind controlled trial of anti-pseudomonas chemotherapy of acute respiratory exacerbations in children with cystic fibrosis. J. Pediatrics 99 (2):307-311, 1981.
15. Boonyaprapa, S., Alderson, P.O., Garfinkel, D.J., Chipps, B.E., Wagner, N.E., Jr: Detection of pulmonary aspiration in infants and children with respiratory disease; concise communication. Journal of Nuclear Medicine Vol 21, #4, 1980.
14. Robotham, J.L., Menkes, H.A., Chipps, B.E., et al: A physiologic assessment of segmental bronchial atresia. American Review of Respiratory Disease 121:533-540, 1980.
13. Chipps, B.E., Kagey - Bobotka, A.K., Valentine, M.D., Schuberth, K.C., Lichtenstein, L.M.: Diagnosis and treatment of anaphylactic reaction to hymenoptera stings. J. Pediatrics Vol. 97, No. 2 1977-1984, 1980.
12. Chipps, B.E., Mak, H., Schuberth, L.S., Talamo, J.H., Scheer, M.S., Menkes, H.A.: Nocturnal oxygen saturation in normal adolescents and asthmatics. Pediatrics Vol 62:1157, 1980.
11. Robotham, J.L., Chipps, B.E., Dorst, J., Shermeta, D.W.: Use of CPAP in hemidiaphragm paralysis. Anesthesiology 52:167-170, 1980.
10. Chipps, B.E., Sobotka, A.K., Sanders, J.P., Teets, K.C., Norman, P.S., Lichtenstein, L.M.: The effect of theophylline and terbutaline on immediate skin tests. J. All Clin. Immunol. Vol
65:61, 1980.
9. Chipps, B.E., Alderson, P.O., Roland, J.M., Yang, S., Van Aswegen, A., Martinez, C., Rosenstein, B.J.: Non-invasive evaluation of ventricular function in cystic fibrosis. Journal of Pediatrics 95:379, 1979.
8. Chipps, B.E., Schuberth, K.C.: Stinging insect hypersensitivity, in: Current Pediatric Therapy, Gellis and Kagan (ed.), W.B. Saunders Co., Philadelphia, 1980.
7. Chipps, B.E., Saulsbury, F.T., Hsu, S.H., Hughes, W.T., Winklestein, J.A.: Non-candidal infections in children with chronic mucocutaneous candidiasis. Johns Hopkins Medical Journal 144:175, 1979.
6. Chipps, B.E., Valentine, M.D., Mellits, E.D., Talamo, R.C.: Immediate (IgE mediated) skin testing in the diagnosis of allergic disease. Ann Allergy 41:211, 1978.
5. Chipps, B.E., Winkelstein, J.A., Talamo, R.C.: IgA deficiency, recurrent pneumonia and bronchiectasis. Chest 73:519, 1978.
4. Chipps, B.E., Swischuk, L.E.: Radiographic single bone involvement in congenital syphilis. Pediatric Radiology 5:50, 1976.
3. Travis, L.B., Street, L., Smith E., Chipps, B.E.: Renal involvement in systemic diseases in childhood, in: The Kidney in Systemic Disease John Wiley & Sons, Inc., New York, 1976.
2. Jorgensen, J.H., Carvajal, H.F., Chipps, B.E., Smith, R.F.: Rapid detection of gram-negative bacteriuria by use of the limulus endotoxin assay. Applied Microbiology 26:38, 1973.
1. Forman, P.M., Chipps, B.E., Myers, G.A.: Managing chronic subdural hematomas and effusions in infants: A continuing dilemma. Texas Medicine 70:62, 1974.